151 related articles for article (PubMed ID: 2469833)
21. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
22. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
Panush RS; Somberg LB; Katz P; Longley S
Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
[TBL] [Abstract][Full Text] [Related]
23. [Production of purified C1q-component of complement and its characteristics].
Nedugova GI; Rubtsov IV
Lab Delo; 1987; (7):542-7. PubMed ID: 2442491
[No Abstract] [Full Text] [Related]
24. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
25. The use of glass as solid phase in enzyme immunoassay as exemplified by the detection of circulating immune complexes.
Schössler W; Hiepe F; Montag T; Schmidt HE
Biomed Biochim Acta; 1985; 44(7-8):1247-53. PubMed ID: 3910036
[TBL] [Abstract][Full Text] [Related]
26. Presence of fucolipid antigens with mono- and dimeric X determinant (Lex) in the circulating immune complexes of patients with adenocarcinoma.
Singhal AK; Singhal MC; Nudelman E; Hakomori S; Balint JP; Grant CK; Snyder HW
Cancer Res; 1987 Nov; 47(21):5566-71. PubMed ID: 2444333
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
Heinz HP; Dlugonska H; Rüde E; Loos M
J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
[TBL] [Abstract][Full Text] [Related]
28. Isolation of virus and antibody containing immune complexes from mink with Aleutian disease by affinity chromatography of equine complement clq.
Burger D; Sriranganathan N; McDonald TL; Gorham JR
Am J Vet Res; 1983 Jan; 44(1):86-90. PubMed ID: 6297342
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
Poulton TA; Mooney NA; Nineham LJ; Hay FC
Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
[TBL] [Abstract][Full Text] [Related]
30. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
31. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
Veerhuis R; van Es LA; Daha MR
Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
[TBL] [Abstract][Full Text] [Related]
32. Rapid three-step purification procedure for isolation of the C1q component of human complement and its use in a solid-phase C1q binding assay.
Bähr EA; Drahovsky D
J Immunol Methods; 1984 Apr; 69(1):43-50. PubMed ID: 6325543
[TBL] [Abstract][Full Text] [Related]
33. Porcine C1q and the solid-phase immunoassay of human immune complexes.
Ziola B; Salmi A; Penttinen K
J Immunol Methods; 1982 Mar; 49(3):247-60. PubMed ID: 6978362
[TBL] [Abstract][Full Text] [Related]
34. C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.
Kolb WP; Kolb LM; Podack ER
J Immunol; 1979 May; 122(5):2103-11. PubMed ID: 109524
[TBL] [Abstract][Full Text] [Related]
35. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
Larsson A; Jonsson L; Sjöquist J
J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
[TBL] [Abstract][Full Text] [Related]
36. Preliminary studies on the detection, isolation and partial characterization of Clq-containing IgM immune complexes in sera of patients with primary biliary cirrhosis.
Willson RA; Balint J
Immunol Lett; 1988 Apr; 17(4):303-9. PubMed ID: 3259541
[TBL] [Abstract][Full Text] [Related]
37. Further evidence for dilution-dependent dissociation of C1q in human serum.
Hosoi S; Borsos T
Complement Inflamm; 1989; 6(4):259-69. PubMed ID: 2788553
[TBL] [Abstract][Full Text] [Related]
38. Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer.
Krieger G; Kneba M; Bolz I; Nagel GA
Clin Immunol Immunopathol; 1988 Jan; 46(1):14-23. PubMed ID: 3257175
[TBL] [Abstract][Full Text] [Related]
39. Influence of immune complex lattice on the C1q solid phase assay as determined with covalently cross-linked immune complexes.
Wener MH; Mannik M
Clin Exp Immunol; 1983 Jun; 52(3):543-50. PubMed ID: 6603296
[TBL] [Abstract][Full Text] [Related]
40. On the interaction of the first complement component C1 and its subunit C1q with solid-phase IgM immune complexes.
Weiner EM
Scand J Immunol; 1988 Oct; 28(4):425-30. PubMed ID: 2461584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
